arrow
D

Deborah Cosentini

University of Brescia
H指数:19
被引数:1,176

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Environmental pollution is associated with poorer survival in patients with adrenocortical carcinoma: findings from a national cohort study in Italy

环境污染与肾上腺皮质癌患者生存率降低相关:来自意大利全国队列研究的结果

2026-09-250
OAAI
P223 - ECE_3069 - SMAC-2 and SMAC-3 cells: characterization of two new ACC patient-derived cell lines

P223 - ECE_3069 - SMAC-2和SMAC-3细胞:两种新的ACC患者来源细胞系的特征鉴定

2026-08-100
OAAI
Prolonged survival in a HER2 positive metastatic breast cancer patient with brain metastases treated with TDM1 after failure of next generation HER2 targeted therapies: case report

HER2阳性脑转移性乳腺癌患者在使用下一代HER2靶向疗法失败后接受TDM1治疗实现长期生存:病例报告

2026-07-290
OA
Updating ACC preclinical models: characterization of two new patient-derived cell lines

更新ACC临床前模型:两种新患者来源细胞系的表征

2026-05-010
PRE
Regional adrenalectomy completed by prophylactic hyperthermic intraperitoneal chemotherapy reduces the incidence of local and peritoneal recurrence after curative surgery for adrenocortical carcinoma

肾上腺区域切除术联合预防性温热腹腔化疗可降低肾上腺皮质癌根治术后局部及腹膜复发的发生率

2026-04-010
PRE
Current clinical management and outcome of patients with adrenal cortical carcinoma (ACC) with rare histological subtypes—an ENSAT cohort study

当前肾上腺皮质癌(ACC)罕见组织学亚型患者的临床管理及预后——一项ENSAT队列研究

2026-03-100
OAAI
Efficacy of RET inhibitors in the management of advanced, RET mutated, pheochromocytoma. Pooled analysis of published cases with the addition of 2 new cases

RET抑制剂在治疗晚期、RET突变型嗜铬细胞瘤中的疗效。已发表病例的合并分析并新增2例病例。

2026-03-090
PRE
Prognostic role of pretreatment [18F]FDG PET/CT in patients affected by adrenocortical carcinoma and treated with chemotherapy

[18F]FDG PET/CT在治疗前预测肾上腺皮质癌患者化疗疗效中的作用

2026-03-060
OAAI
Preclinical evaluation of progesterone combined with EDP-M scheme in 2D and 3D models of adrenocortical carcinoma

孕酮联合EDP-M方案在肾上腺皮质癌2D和3D模型中的临床前评估

2026-02-100
OAAI
Chemo-immunotherapy with cisplatin and nivolumab as second-line approach in metastatic adrenocortical carcinoma

顺铂和纳武利尤单抗联合化疗免疫疗法作为转移性肾上腺皮质癌的二线治疗策略

2026-02-010
PRE
Fracture risk in metastatic breast cancer patients treated with CDK 4/6 inhibitors and endocrine therapy
2026-01-200
PRE
Clinical Presentation, Prognosis, and Treatment Strategies for Thymoma-Associated Multiorgan Autoimmunity: A Pooled Analysis.

胸腺瘤相关多器官自身免疫的临床表现、预后及治疗策略:一项合并分析。

2025-12-030
PRE